SCOTT SANDERS M.D. NPI 1780670927

NPI Details

Scott Sanders, M.D. is a dermatopathology dermatology in New City, NY with 28 years of experience. The provider is a dermatopathologist has the expertise to diagnose and monitor diseases of the skin including infectious, immunologic, degenerative and neoplastic diseases. This entails the examination and interpretation of specially prepared tissue sections, cellular scrapings and smears of skin lesions by means of routine and special (electron and fluorescent) microscopes. Scott Sanders, M.D. NPI is 1780670927. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: HARVARD MEDICAL SCHOOL
Graduation Year:1998

The provider's business location address is:

301 N MAIN ST
SUITE 3
NEW CITY, NY
ZIP 10956-021
Phone: (845) 499-2017
Fax: (845) 499-2018

The NPI 1780670927 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 33D2076613 - physician office with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tildrakizumab, 1 mg (HCPCS:J3245)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Test for allergy using skin patch (HCPCS:95044)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Treatment of inflammatory skin disease using laser, less than 250.0 sq cm (HCPCS:96920)
• Therapy procedure using ultraviolet radiation with tar or petroleum jelly application (HCPCS:96910)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm (HCPCS:96921)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Acne surgery (HCPCS:10040)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Punch biopsy, first skin growth (HCPCS:11104)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Biopsy of ear (HCPCS:69100)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Punch biopsy, each additional skin growth (HCPCS:11105)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Removal of skin tag, 1-15 skin tags (HCPCS:11200)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 9/22/2005 and was last updated on 2/18/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: